Search research articles
Contact Us
Filters
Showing results (511-520 of 581) with videos related to
Page
of 59
Sort By:
The American Journal of Surgical Pathology
|
May 29, 2019
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies
Henning Reis, Rene Serrette, Jennifer Posada, et al.
Human Pathology
|
March 19, 2017
Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists
Sean R Williamson, Ramya Gadde, Kiril Trpkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Martin H Voss, Ana M Molina, Ying-Bei Chen, et al.
Cancer Cell
|
January 15, 2016
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A Ari Hakimi, Ed Reznik, Chung-Han Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2014
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
Martin H Voss, A Ari Hakimi, Can G Pham, et al.
Human Pathology
|
March 31, 2018
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma
Sumit Isharwal, Hongying Huang, Gouri Nanjangud, et al.
European Urology
|
August 6, 2014
Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
Philip H Kim, Eugene K Cha, John P Sfakianos, et al.
The Journal of Urology
|
January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma
Aditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2021
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma
Kyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, et al.
European Urology Focus
|
September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma
Jozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
Page
of 59
Search research articles
Search
Showing results (511-520 of 581) with videos related to
Sort By:
Page
of 59
The American Journal of Surgical Pathology
|
May 29, 2019
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies
Henning Reis, Rene Serrette, Jennifer Posada, et al.
Human Pathology
|
March 19, 2017
Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists
Sean R Williamson, Ramya Gadde, Kiril Trpkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Martin H Voss, Ana M Molina, Ying-Bei Chen, et al.
Cancer Cell
|
January 15, 2016
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A Ari Hakimi, Ed Reznik, Chung-Han Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2014
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
Martin H Voss, A Ari Hakimi, Can G Pham, et al.
Human Pathology
|
March 31, 2018
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma
Sumit Isharwal, Hongying Huang, Gouri Nanjangud, et al.
European Urology
|
August 6, 2014
Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
Philip H Kim, Eugene K Cha, John P Sfakianos, et al.
The Journal of Urology
|
January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma
Aditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2021
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma
Kyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, et al.
European Urology Focus
|
September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma
Jozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
Page
of 59